Showing papers in "Journal of Substance Abuse Treatment in 2021"

TL;DR: While SAMSHA guidance should allow expanded access to take-home doses, adoption of these guidelines may vary at the clinic level, particularly in the context of benefits to patients seeking OUD treatment.

TL;DR: Simulation modeling was employed to demonstrate the potential impact of physical distancing on overdose mortality and the degree to which COVID-19 will impact the opioid epidemic and through which of the possible mechanisms that are important to monitor.

TL;DR: In this article, two harm reduction primary care programs in New York State that care for people who use drugs and offer buprenorphine, one rural (Ithaca) and one urban (Manhattan).

TL;DR: Reductions in the accessibility of critical services PWUD rely on during COVID-19 has increased existent substance use and health issues among PWUD, while decreasing their ability to mitigate risks related to substance use.

TL;DR: In this article, the authors conducted a comprehensive state-wide survey of all eight OTPs that dispense methadone in Connecticut to examine programmatic changes during COVID-19.

TL;DR: The impact of the COVID-19 pandemic and accompanying policy changes on service delivery in the U.S. was explored in this article, where the authors asked OTP clinicians about changes in care patterns and perceptions of impacts on access and quality.

TL;DR: Efforts should prioritize interventions to improve retention among patients who are both prescribed and dispended MOUD, especially youth, people experiencing homelessness, polysubstance users, and people referred to care by the justice system who have especially short stays in care.

TL;DR: When in-person treatment and recovery support services are limited, as is the case during the COVID-19 pandemic, expected therapeutic benefits and emerging data, taken together, suggest providers, mentors, and other community leaders may wish to refer individuals to social-online D-RSS.

TL;DR: Study findings highlight COVID-related threats to the survival of residential Sud treatment programs; retention of the SUD treatment workforce; and clients' SUD Treatment outcomes and identify opportunities to improve SUD service delivery.

TL;DR: This report recommends that methadone should be delivered to patients’ homes, and eventually accessible in community pharmacies, and lifting the X-waiver requirement would increase buprenorphine access.

TL;DR: It is advocated that OTPs rely less on toxicology testing and more on the other patient-centered measures to guide decisions about distribution of take-home doses of MOUD, and for the reassessment of OTP reimbursement models.

TL;DR: It is suggested that the urgency and public spiritedness of the response to COVID-19 be harnessed to make gains on the opioid cascade, inspiring prescribers, health systems, and communities to embrace the delivery of MOUD to meet the needs of an increasingly vulnerable population.

TL;DR: Future state and federal policy should focus on maintaining less stringent policies around the use of telehealth, prescribing, and in-person exams for medication for OUD.

TL;DR: It is suggested that individuals with a history of using multiple substances may be at greater risk for poor outcomes due to COVID-19, even in the face of expansion of telehealth service access.

TL;DR: Recovery coaches may be an impactful and potentially cost-effective addition to an SUD care team, but future research is needed that uses a matched comparison condition.

TL;DR: Primary care providers and other general practitioners who frequently interface with youth should increase their baseline screening of youth and utilize considerable opportunities for virtual care to reach adolescents at risk of developing a substance use disorder and/or those who may already have relapsed.

TL;DR: In this article, the authors proposed a tele-bridge clinic where people with opioid use disorder can be linked with a buprenorphine prescriber in real-time for OUD assessment and initiation with connection to follow-up if appropriate.

TL;DR: It is argued that MouD counseling is achievable via telehealth and the need for, and anticipated benefits of, hybrid telehealth/in-person MOUD treatment models moving forward are outlined.

TL;DR: In this article, the authors describe the impact of the COVID-19 pandemic on the delivery of treatment for substance use disorders (SUDs) from the perspectives of service providers.

TL;DR: OAT delivery has improved and become more efficient, but clinicians should plan long-term should COVID-19 return in the near future, and if the new efficiencies are maintained, it will free the workforce to further scale up OAT.

TL;DR: A systematic literature review of stigma interventions for providers who treat patients with substance use disorders (SUDs) is presented in this article, in order to evaluate the quality of existing studies and potential for implementation in clinical settings.

TL;DR: Gender disparities existed in both access and retention where women spent more time than men waiting to enter treatment but then remained in treatment longer, and female clients identifying as African American, Latino, and Other were at greater risk for shorter treatment duration.

TL;DR: It is argued that the mother of the next innovation should be a public call for a progressive, thoughtful set of public health policies and other external setting levers to address the needs of those with OUD and the OTPs that serve them.

TL;DR: Two essential changes that Homeless Health Care Los Angeles (HHCLA) made to modify existing medication for addiction treatment (MAT) services to address the specific treatment needs of this high-risk population during COVID-19 are discussed.

TL;DR: With a decreased jail census, the use of remote visits, and modifications to the buprenorphine treatment program, clinicians are able to meet the OUD treatment demand.

TL;DR: A multidisciplinary ALD clinic was feasible with encouraging early outcomes, and ways to expand this model and increase clinic capacity should be explored.

TL;DR: It is proposed that practitioners should stop using routine UDT and instead use targeted UDT, paired with clinical reasoning, as part of a patient-centered approach to care.

TL;DR: The Harm Reduction and BRidges to Care (HRBRidges to care) clinic as mentioned in this paper is an on-demand, low barrier addiction clinic that opened in October 2019 and has seen steadily increasing numbers of patients.

TL;DR: DynamiCare Health is feasible and potentially beneficial as a complement to community substance use treatment programs, and sustained app utilization was associated with a wide range of usual care treatment participation.

TL;DR: Patients who would not otherwise qualify for large quantities of take-home methadone when it is dispensed via a secure pillbox were able to adequately manage when the integration of a commercially available pillbox into routine clinic operations increases opportunity for dispensing medication.